Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Toward The Establishment Of Standardized In Vitro Tests For Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During The In Vitro Digestion Of Type I, II, IIIA, IIIB And IV Lipid-Based Formulations

H. Williams, P. Sassene, Karen Kleberg, Marilyn Calderone, A. Igonin, Eduardo Jule, J. Vertommen, Ross D. Blundell, H. Benameur, A. Müllertz, C. Pouton, C. H. Porter, on behalf of the Lfcs Consortium
Published 2013 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
PurposeRecent studies have shown that digestion of lipid-based formulations (LBFs) can stimulate both supersaturation and precipitation. The current study has evaluated the drug, formulation and dose-dependence of the supersaturation – precipitation balance for a range of LBFs.MethodsType I, II, IIIA/B LBFs containing medium-chain (MC) or long-chain (LC) lipids, and lipid-free Type IV LBF incorporating different doses of fenofibrate or tolfenamic acid were digested in vitro in a simulated intestinal medium. The degree of supersaturation was assessed through comparison of drug concentrations in aqueous digestion phases (APDIGEST) during LBF digestion and the equilibrium drug solubility in the same phases.ResultsIncreasing fenofibrate or tolfenamic acid drug loads (i.e., dose) had negligible effects on LC LBF performance during digestion, but promoted drug crystallization (confirmed by XRPD) from MC and Type IV LBF. Drug crystallization was only evident in instances when the calculated maximum supersaturation ratio (SRM) was >3. This threshold SRM value was remarkably consistent across all LBF and was also consistent with previous studies with danazol.ConclusionsThe maximum supersaturation ratio (SRM) provides an indication of the supersaturation ‘pressure’ exerted by formulation digestion and is strongly predictive of the likelihood of drug precipitation in vitro. This may also prove effective in discriminating the in vivo performance of LBFs.
This paper references
Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?
J. Brouwers (2009)
Strategies to Address Low Drug Solubility in Discovery and Development
H. Williams (2013)
Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.
M. Vogt (2008)
Micronized Fenofibrate
D. Kiortsis (2002)
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
C. H. Porter (2008)
Protein purification by bulk crystallization: the recovery of ovalbumin.
R. Judge (1995)
Effect of different nonionic surfactants in self-emulsifying lipid formulations on supersaturation during in vitro digestion
R Devraj (2013)
Toward Standardized Tests for Lipid-Based Formulations
Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension.
Y. E. Arnold (2011)
Oral lipid-based formulations : enhancing the bioavailability of poorly water-soluable drugs
D. Hauss (2007)
Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.
Ping Gao (2009)
Characterizing the Impact of Hydroxypropylmethyl Cellulose on the Growth and Nucleation Kinetics of Felodipine from Supersaturated Solutions
David E. Alonzo (2012)
Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies.
P. Constantinides (2007)
Kinetics of crystal nucleation in silicate glasses
P. James (1985)
Effect of molecular weight, temperature, and additives on the moisture sorption properties of polyethylene glycol.
Jared A. Baird (2010)
Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.
Jan Bevernage (2013)
Understanding the solid-state forms of fenofibrate--a spectroscopic and computational study.
A. Heinz (2009)
Characterization and Physical Stability of Tolfenamic Acid-PVP K30 Solid Dispersions
Pia Thybo (2007)
Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid.
Jonas H. Fagerberg (2012)
Enhancing the bioavailability of poorly water-soluble drugs
Dj Hauss (2007)
Toward the establishment of standardized in vitro tests for lipid-based formulations: 3) Effect of calcium and pancreatin concentration
P Sassene (2013)
Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate.
P. Sassene (2010)
Trends in solubility of polymorphs.
M. Pudipeddi (2005)
Inhibition of solution crystal growth of ritonavir by cellulose polymers – factors influencing polymer effectiveness
Grace A. Ilevbare (2012)
Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update☆
Natalie L Trevaskis (2008)
Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?
S. Murdande (2011)
Lipid Absorption Triggers Drug Supersaturation at the Intestinal Unstirred Water Layer and Promotes Drug Absorption from Mixed Micelles
Yan Yan Yeap (2013)
The effects of excipients on transporter mediated absorption.
J. Goole (2010)
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.
C. H. Porter (2004)
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation
C. H. Porter (2004)
Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs
Jean F Cuiné (2006)
Review: Nucleation in solutions revisited
D. Kashchiev (2003)
Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels
P. Sassene (2014)
The effect of oral lipids and circulating lipoproteins on the metabolism of drugs
Jigar P. Patel (2009)
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.
Greg A Kossena (2003)
Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.
M. U. Anby (2012)
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
C. Pouton (2006)
Poorly soluble marketed drugs display solvation limited solubility.
C. Bergström (2007)
Rate of Nucleation in Condensed Systems
D. Turnbull (1949)
Toward in silico prediction of glass-forming ability from molecular structure alone: a screening tool in early drug development.
D. Mahlin (2011)
Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products
L. Sek (2002)
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations.
H. Williams (2012)
Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway
H. Williams (2013)
The acidic microclimate of the intestinal unstirred water layer can promote drug absorption from long-chain mixed micelles via induction of supersaturation at the absorptive site
Yy Yeap
Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.
Michiel van Speybroeck (2010)
Effect of different nonionic surfactants in self-emulsifying lipid formulations on supersaturation during in vitro
R Devraj (2013)
Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids.
T. Osterberg (2001)
Natalie L Trevaskis (2006)
Drug precipitation-permeation interplay: supersaturation in an absorptive environment.
Jan Bevernage (2012)
Cryst Growth Des
Pg Vekilov (2010)
Lipid-based formulations for intestinal lymphatic delivery.
C. O'Driscoll (2002)
Characterization of two polymorphic forms of tolfenamic acid, N-(2-methyl-3-chlorophenyl)anthranilic acid: their crystal structures and relative stabilities
K. Andersen (1989)
Self-Emulsifying Drug Delivery Systems: Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound
S. Charman (2004)
Lipid digestion as a trigger for supersaturation: in vitro and in vivo evaluation of the utility of polymeric precipitation inhibitors in self emulsifying drug delivery systems
Mu Anby (2012)
Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.
H. Williams (2012)
Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
Yan Yan Yeap (2013)
Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells.
T. Lindmark (1998)
Drug supersaturation in digested lipid-based drug delivery systems
Hd Williams
A classification system to assess the crystallization tendency of organic molecules from undercooled melts.
Jared A. Baird (2010)
Thermodynamic and structural study of tolfenamic acid polymorphs.
A. Surov (2009)
Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats
A. Dahan (2006)
Polymorph Formation and Nucleation Mechanism of Tolfenamic Acid in Solution: An Investigation of Pre-nucleation Solute Association
A. Mattei (2011)

This paper is referenced by
Critical In Vitro Characterization Methods of Lipid-Based Formulations for Oral Delivery: a Comprehensive Review
N. K. Swarnakar (2018)
Supersaturated Lipid-Based Formulations to Enhance the Oral Bioavailability of Venetoclax
N. Koehl (2020)
A Nonionic Polyethylene Oxide (PEO) Surfactant Model: Experimental and Molecular Dynamics Studies of Kolliphor EL.
Estelle J A Suys (2019)
Comparison of lipases for in vitro models of gastric digestion: lipolysis using two infant formulas as model substrates.
P. Sassene (2016)
Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media
Ahmed Elkhabaz (2019)
Biopharmaceutical Modeling of Drug Supersaturation During Lipid-Based Formulation Digestion Considering an Absorption Sink
Cordula Stillhart (2014)
Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis.
Paloma Benito-Gallo (2015)
Drug-excipient-shell interactions using thermoplastic starch-based capsules for oral lipid-based drug delivery
Philosophisch-naturwissenschaftlichen Fakultät (2014)
A new in vitro lipid digestion – in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations
Matthew F. Crum (2015)
A New Strategy for Enhancing the Oral Bioavailability of Drugs with Poor Water-Solubility and Low Liposolubility Based on Phospholipid Complex and Supersaturated SEDDS
H. Zhou (2013)
Toward an improved understanding of the precipitation behavior of weakly basic drugs from oral lipid-based formulations.
Cordula Stillhart (2014)
Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity.
V. Jannin (2015)
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
Claire L McEvoy (2017)
The gut in the beaker: Missing the surfactants?
C. Wilson (2016)
Lipid Absorption Triggers Drug Supersaturation at the Intestinal Unstirred Water Layer and Promotes Drug Absorption from Mixed Micelles
Yan Yan Yeap (2013)
Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view
B. Chatterjee (2016)
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Linda C Alskär (2015)
Do drug release studies from SEDDS make any sense?
A. Bernkop-Schnürch (2018)
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system.
H. Williams (2014)
Improved Molecular Understanding of Lipid-Based Formulations : for Enabling Oral Delivery of Poorly Water-Soluble Drugs
Linda C Alskär (2018)
Tools for Early Prediction of Drug Loading in Lipid-Based Formulations
Linda C Alskär (2016)
years of oral lipid-based formulations : Provenance , progress and future perspectives ☆
O. Feeney (2016)
Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate.
B. Griffin (2014)
Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.
F. Carrière (2016)
In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems.
P. Sassene (2016)
Interactions of Artefenomel (OZ439) with Milk during Digestion: Insights into Digestion-Driven Solubilization and Polymorphic Transformations.
M. Salim (2018)
Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion formulation.
Aude Pestieau (2015)
50years of oral lipid-based formulations: Provenance, progress and future perspectives.
O. Feeney (2016)
In Situ Lipolysis and Synchrotron Small-Angle X-ray Scattering for the Direct Determination of the Precipitation and Solid-State Form of a Poorly Water-Soluble Drug During Digestion of a Lipid-Based Formulation.
J. Khan (2016)
Bio-relevant characterisation of lipidic formulations and prediction of in vivo exposure
Paloma Benito-Gallo (2017)
Gastrointestinal and Systemic Monitoring of Posaconazole in Humans After Fasted and Fed State Administration of a Solid Dispersion.
B. Hens (2016)
Lipid-Based Formulations
Justin S. Lafountaine (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar